1-(3-methoxybenzo[b][1]benzoxepin-5-yl)-4-methylpiperazine
- Molecular formula
- C19H22N2O2
- CAS Number
- 1029144-16-9
- IUPAC Name
- 1-(3-methoxybenzo[b][1]benzoxepin-5-yl)-4-methyl-piperazine
- Molecular Weight
- 310.39g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 1.3000g/cm3
- Synonyms
- Metoxepin
Identification
Interesting Facts about 1-(3-methoxybenzob[1]benzoxepin-5-yl)-4-methyl-piperazine
This compound represents a fascinating intersection of synthetic organic chemistry and pharmacology. It is an example of a complex molecule that incorporates multiple functional groups and structural motifs, making it a valuable subject of study.
Key Features:
- Multi-Structural Components: The presence of the methoxy group and piperazine ring adds to the versatility of the compound, influencing its reactivity and interactions.
- Potential Biological Activity: Compounds of this nature have been investigated for their potential pharmacological effects, especially in the realm of neuropharmacology.
- Versatility in Synthesis: The synthesis of such compounds often involves sophisticated organic reactions, including substitutions and cyclizations, showcasing advanced synthetic techniques in organic chemistry.
- Research Interest: Researchers are intrigued by these types of compounds due to their potential applications in drug development, especially in targeting specific receptors in the brain.
“Understanding complex molecules is key to advancing therapeutic strategies.” This sentiment resonates within the scientific community as compounds like this one are pivotal for innovation in medicinal chemistry.
Given its structural complexity, 1-(3-methoxybenzob[1]benzoxepin-5-yl)-4-methyl-piperazine serves as an excellent model for studying molecular interactions, receptor binding affinities, and the development of new pathways for therapeutic agents. Its synthesis not only demonstrates the creativity of chemists but also reinforces the importance of interdisciplinary collaboration in addressing health challenges.